NeuroPace, Inc. (NPCE)
NASDAQ: NPCE · Real-Time Price · USD
12.91
-0.23 (-1.75%)
Oct 23, 2026, 4:00 PM EDT - Market closed

NeuroPace Revenue

NeuroPace had revenue of $22.83M in the quarter ending June 30, 2026, with 17.05% growth. This brings the company's total for the last twelve months to $98.84M, up 16.90% year-over-year. In the year 2025, NeuroPace had annual revenue of $99.99M with 25.13% growth. That makes NeuroPace the 22,145th largest company in the world by revenue and 3,244th in the United States.

Revenue (ttm)
$98.84M
Revenue Growth
+16.90%
P/S Ratio
4.14
Revenue / Employee
$486,332
Employees
220
Market Cap
443.13M

Revenue Chart

Revenue by Geography

  • United States 99.09M 99.1%
  • Foreign 900.00K 0.9%
Fiscal year ended Dec 31, 2025 See the full NeuroPace breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202599.99M20.08M25.13%
Dec 31, 202479.91M14.49M22.14%
Dec 31, 202365.42M19.90M43.72%
Dec 31, 202245.52M337.00K0.75%
Dec 31, 202145.18M4.05M9.83%
Dec 31, 202041.14M4.17M11.27%
Dec 31, 201936.97M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Orthofix Medical833.19M
Viemed Healthcare301.61M
Cerus221.55M
Delcath Systems95.42M
Sight Sciences83.38M
AVITA Medical75.63M
908 Devices60.84M
BrainsWay60.70M
Revenue Rankings